Immune Globulin Intravenous (Human), 10% (IGIV, 10%) 400 mg/kg
160701
Phase 3 mab completed
Quick answer
Immune Globulin Intravenous (Human), 10% (IGIV, 10%) 400 mg/kg for Alzheimer´s Disease is a Phase 3 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Alzheimer´s Disease
- Phase
- Phase 3
- Modality
- mab
- Status
- completed